I tend to agree.
About the only thing that would send this stock to $15 in 10 days is the bioprinting of Jesus before Christmas!
Bad earnings from various DOW components, general attack on 3D marketplace, pessimism about the budget deal in Congress, no news from ONVO conference.
In other words, a perfect storm for shorts (at least for a day).
I'm optimistic, but the liver assay product will not be available until next December, according to the CEO.
Congrats on your persistence.
Has Congress voted on that bill yet?
They go on recess after Friday through the end of the year, so they need to vote on it this week, or during the first week in January.
I'm completely aware of the tissue-testing marketplace.
However, immunological vaccines is where most of the MONEY is going now and in the future. T-cell response testing can realistically only be done IN a fully functioning human body; not simply in surrogate tissue(s). (Not even on the famous "body on a chip.") Please do research before spouting ad hominem invectives.
Bioprinting has virtually nothing to do with curing cancer. They are two mutually exclusive market segments.
What are you trying to say?
Agreed. All I'm saying is that we won't see a huge movement in the stock price until one or more of these collaborations with BIG PHARMA is actually announced.
There is some promise here, but the video clip was somewhat underwhelming.
We need much more than University collaboration, though.
We need BIG PHARMA collaboration. That is what will really move a stock higher.